Pharmacy Times Presents
Virtual Directions in Pharmacy – 11th annual
Directions in Pharmacy® 2021 – Live Free CE-accredited Virtual Broadcast!
Saturday, March 20, 2021
8:00 AM – 3:30 PM Central Time
Copy and paste below to make your reservation.
Earn up to 6.0 Live CE Credits
Pharmacists, now more than ever, continue to assist patients with understanding best practices to manage their health as well as the health of their families, so it is imperative that pharmacists are equipped with the most current and relevant information. For over a decade, the Directions in Pharmacy® spring conference has offered pharmacists practicing in community, health-system, and other areas of health care the opportunity to participate in various interactive sessions. The evolution of patient care in these settings has expanded the role of pharmacists due to continuous advancements in the treatment and prevention of many diseases. These sessions will highlight disease-state management, clinical data, and treatment guidelines as well as best practices for optimizing patient care for a wide variety of therapeutic areas. Topics will include management of respiratory illnesses and cardiovascular diseases as well as immunization recommendations.
Educational Objectives for Attending Pharmacists
Upon completion of this educational conference, pharmacists should be able to:
- Examine the burden of infectious diseases and the evolving landscape of their management, including a review of efficacy and safety of COVID-19, influenza and pneumococcal vaccines, as well as antivirals used in the treatment and prevention of influenza
- Analyze current guidelines for cardiovascular diseases including the management of heart failure and cholesterol as well as how new and emerging agents may fit into the treatment paradigm
- Identify the role of pharmacists in educating the health care team and patients, counseling on adverse effects, promoting patient adherence, and individualizing care to improve patient outcomes when managing various diseases and offering contraceptive care
This continuing education program is directed toward pharmacists practicing in the community and health-system settings.
Topics will include:
- COVID-19 vaccines
- Influenza vaccines
- Influenza treatment and prevention with antivirals
- Pneumococcal vaccines
- Heart failure
- LDL-C lowering in patients with statin intolerance
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
All participants who attended the live virtual broadcast need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Instructions on receiving credit will be provided the day of the live symposium.
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty disclosures will be provided before the presentation.
The following contributors have relevant financial relationships with commercial interests to disclose:
Pharmacy Times Continuing Education™
Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Liza Patel, PharmD, RPh; Brianna Schauer, MBA, PMP; Ann Marciano; Crissy Wilson; Susan Pordon; and Brianna Winters.
Anonymous peer reviewers are used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ (PTCE) strives to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events hosted by PTCE. PTCE reserves the right to cancel an event without notice. PTCE will not be responsible for any expenditure incurred due to the cancellation.
Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Terms and Conditions: